Multiomic meta-analysis of differential response to PD-1 and CTLA-4 blockade in metastatic melanoma

被引：0
|
作者：
Huang, Amy Y.
Vokes, Natalie
Ricker, Cora
Aprati, Tyler
Robitschek, Emily
Yang, Jiekun
Ho, Li-Lun
Galani, Kyriakitsa
Burke, Kelly P.
Tarantino, Giuseppe
Chen, Jiajia
Sharpe, Arlene H.
Van Allen, Eliezer M.
Kellis, Manolis
Boland, Genevieve M.
Liu, David
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3271
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3271
引用
收藏
页数：3
相关论文
共 50 条
  • [1] MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
    Rodig, Scott J.
    Gusenleitner, Daniel
    Jackson, Donald G.
    Gjini, Evisa
    Giobbie-Hurder, Anita
    Jin, Chelsea
    Chang, Han
    Lovitch, Scott B.
    Horak, Christine
    Weber, Jeffrey S.
    Weirather, Jason L.
    Wolchok, Jedd D.
    Postow, Michael A.
    Pavlick, Anna C.
    Chesney, Jason
    Hodi, F. Stephen
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (450)
  • [2] Molecular and immune predictors of response and toxicity to combined CTLA-4 and PD-1 blockade in metastatic melanoma (MM) patients (pts).
    Chen, Wei-Shen
    Cameron, Miles
    Spencer, Christine
    Tawbi, Hussein Abdul-Hassan
    Lazar, Alexander
    Tetzlaff, Michael T.
    Patel, Sapna Pradyuman
    Hwu, Patrick
    Hwu, Wen-Jen
    Diab, Adi
    Glitza, Isabella Claudia
    Amaria, Rodabe Navroze
    Burton, Elizabeth M.
    Woodman, Scott Eric
    Davies, Michael A.
    Gershenwald, Jeffrey E.
    Sharma, Padmanee
    Allison, James Patrick
    Futreal, Andrew
    Wargo, Jennifer Ann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis
    Kongju Wu
    Ming Yi
    Shuang Qin
    Qian Chu
    Xinhua Zheng
    Kongming Wu
    [J]. Experimental Hematology & Oncology, 8
  • [4] The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis
    Wu, Kongju
    Yi, Ming
    Qin, Shuang
    Chu, Qian
    Zheng, Xinhua
    Wu, Kongming
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [5] Tolerance and Efficacy of Combined Nivolumab and Ipilimumab Following Monotherapy with PD-1 or CTLA-4 Blockade in Metastatic Melanoma
    Randhawa, M.
    Nguyen, B.
    Ali, S.
    Yip, D.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 71 - 71
  • [6] Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
    Gangaev, Anastasia
    Rozeman, Elisa A.
    Rohaan, Maartje W.
    Isaeva, Olga I.
    Philips, Daisy
    Patiwael, Sanne
    van den Berg, Joost H.
    Ribas, Antoni
    Schadendorf, Dirk
    Schilling, Bastian
    Schumacher, Ton N.
    Blank, Christian U.
    Haanen, John B. A. G.
    Kvistborg, Pia
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (43)
  • [7] Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
    Van Allen, Eliezer M.
    Miao, Diana
    Schilling, Bastian
    Shukla, Sachet A.
    Blank, Christian
    Zimmer, Lisa
    Sucker, Antje
    Hillen, Uwe
    Foppen, Marnix H. Geukes
    Goldinger, Simone M.
    Utikal, Jochen
    Hassel, Jessica C.
    Weide, Benjamin
    Kaehler, Katharina C.
    Loquai, Carmen
    Mohr, Peter
    Gutzmer, Ralf
    Dummer, Reinhard
    Gabriel, Stacey
    Wu, Catherine J.
    Schadendorf, Dirk
    Garraway, Levi A.
    [J]. SCIENCE, 2015, 350 (6257) : 207 - 211
  • [8] CTLA-4 and PD-1 pathway blockade: combinations in the clinic
    Callahan, Margaret K.
    Postow, Michael A.
    Wolchok, Jedd D.
    [J]. FRONTIERS IN ONCOLOGY, 2015, 4
  • [9] Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
    Werner, Jan-Michael
    Schweinsberg, Viola
    Schroeter, Michael
    von Reutern, Boris
    Malter, Michael P.
    Schlaak, Max
    Fink, Gereon R.
    Mauch, Cornelia
    Galldiks, Norbert
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world study
    Avital Klein-Brill
    Shlomit Amar-Farkash
    Keren Rosenberg-Katz
    Ronen Brenner
    Jürgen C. Becker
    Dvir Aran
    [J]. BJC Reports, 2 (1):
12345